Literature DB >> 4061546

Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years.

J A Shields, J J Augsburger, L A Donoso, V B Bernardino, M Portenar.   

Abstract

A 70-year-old woman who had undergone enucleation of the left eye at the age of 28 years because of complications from an injury to the globe, and in whom a previously unsuspected posterior uveal melanoma was detected after enucleation, had no further problems until 42 years later, when she was discovered to have a liver malignancy of undetermined origin. After six months of chemotherapy, the patient developed a mass in the anophthalmic left orbit. Biopsy of the orbital mass disclosed malignant melanoma, and reexamination of the liver biopsy specimen disclosed similar malignant melanoma cells. The patient had no clinical evidence of a primary melanoma other than the one involving the eye. It is possible that the patient had subclinical melanoma cells in the liver for 40 years. However, another possibility is that the patient had residual melanoma cells in the orbit which eventually metastasized to the liver.

Entities:  

Mesh:

Year:  1985        PMID: 4061546     DOI: 10.1016/0002-9394(85)90621-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  Imaging of ocular melanoma metastasis.

Authors:  Rashmi Balasubramanya; Santosh Kumar Selvarajan; Mougnyan Cox; Ganesh Joshi; Sandeep Deshmukh; Donald G Mitchell; Patrick O'Kane
Journal:  Br J Radiol       Date:  2016-05-31       Impact factor: 3.039

2.  Modelling uveal melanoma.

Authors:  A J Foss; I A Cree; P J Dolin; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.

Authors:  Michael A Coutts; Nicola J Borthwick; John L Hungerford; Ian A Cree
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

4.  Enucleation combined with orbital implants for malignant melanoma of the uvea.

Authors:  J Sassmannshausen; N Bornfeld; A Kluge; W Sauerwein; F Härting; A Wessing
Journal:  Int Ophthalmol       Date:  1989-07       Impact factor: 2.031

5.  Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.

Authors:  Paul R van Ginkel; Soesiawati R Darjatmoko; Dhruv Sareen; Lalita Subramanian; Saswati Bhattacharya; Mary J Lindstrom; Daniel M Albert; Arthur S Polans
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Authors:  X Q Huang; M S Mitchell; P E Liggett; A L Murphree; J Kan-Mitchell
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

7.  Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

Authors:  James J Augsburger; Zélia M Corrêa; Adeel H Shaikh
Journal:  Trans Am Ophthalmol Soc       Date:  2008

8.  Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.

Authors:  Constantine G A Theoharis; Tobias Carling; Natalia Buza; Eduardo Zambrano; Julie Ann Sosa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

9.  Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.

Authors:  J Kan-Mitchell; P E Liggett; W Harel; L Steinman; T Nitta; J R Oksenberg; M R Posner; M S Mitchell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Authors:  Christine D M Roelofsen; Annemijn P A Wierenga; Sjoerd van Duinen; Robert M Verdijk; Jaco Bleeker; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2020-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.